Géraldine Cancel‐Tassin

18.7k total citations · 3 hit papers
123 papers, 5.2k citations indexed

About

Géraldine Cancel‐Tassin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Géraldine Cancel‐Tassin has authored 123 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 58 papers in Pulmonary and Respiratory Medicine and 32 papers in Cellular and Molecular Neuroscience. Recurrent topics in Géraldine Cancel‐Tassin's work include Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (40 papers) and Genetic Neurodegenerative Diseases (31 papers). Géraldine Cancel‐Tassin is often cited by papers focused on Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (40 papers) and Genetic Neurodegenerative Diseases (31 papers). Géraldine Cancel‐Tassin collaborates with scholars based in France, United States and United Kingdom. Géraldine Cancel‐Tassin's co-authors include Alexis Brice, Giovanni Stévanin, Yves Agid, Olivier Cussenot, Alexandra Dürr, Jean‐Louis Mandel, C. R. Weber, Georges Imbert, Frédéric Saudou and Yvon Trottier and has published in prestigious journals such as Nature, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Géraldine Cancel‐Tassin

117 papers receiving 5.1k citations

Hit Papers

Cloning of the gene for spinocerebellar ataxia 2 reveals ... 1995 2026 2005 2015 1996 1997 1995 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats
    1996 706 citations Yvon Trottier, C. R. Weber et al. Nature Genetics profile →
  2. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion
    1997 599 citations Gilles David, Nacer Abbas et al. Nature Genetics profile →
  3. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias
    1995 540 citations Yvon Trottier, Yves Lutz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Géraldine Cancel‐Tassin France 33 3.6k 3.2k 1.4k 836 406 123 5.2k
Steven L. Carroll United States 35 1.4k 0.4× 1.2k 0.4× 960 0.7× 400 0.5× 312 0.8× 105 3.8k
Mary B. Davis United Kingdom 39 2.3k 0.6× 1.8k 0.6× 1.2k 0.9× 115 0.1× 461 1.1× 111 4.3k
Iver A. Langmoen Norway 36 1.5k 0.4× 1.4k 0.4× 478 0.4× 255 0.3× 129 0.3× 112 3.8k
Murat Günel United States 43 2.5k 0.7× 563 0.2× 2.6k 1.9× 833 1.0× 982 2.4× 135 6.6k
Wim G.M. Spliet Netherlands 44 1.8k 0.5× 1.2k 0.4× 982 0.7× 487 0.6× 587 1.4× 108 5.4k
Claude‐Alain Maurage France 38 1.5k 0.4× 532 0.2× 1.3k 0.9× 393 0.5× 147 0.4× 135 4.4k
Federico Zara Italy 46 3.0k 0.8× 1.3k 0.4× 878 0.6× 195 0.2× 2.3k 5.7× 242 6.6k
Kinga Szigeti United States 24 933 0.3× 812 0.3× 700 0.5× 276 0.3× 239 0.6× 64 2.9k
Ana Martín-Villalba Germany 37 3.2k 0.9× 1.3k 0.4× 449 0.3× 167 0.2× 341 0.8× 69 5.7k
Wolfgang Roggendorf Germany 38 1.5k 0.4× 702 0.2× 1.2k 0.9× 324 0.4× 142 0.3× 109 4.7k

Countries citing papers authored by Géraldine Cancel‐Tassin

Since Specialization
Citations

This map shows the geographic impact of Géraldine Cancel‐Tassin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Cancel‐Tassin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Cancel‐Tassin more than expected).

Fields of papers citing papers by Géraldine Cancel‐Tassin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Cancel‐Tassin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Cancel‐Tassin. The network helps show where Géraldine Cancel‐Tassin may publish in the future.

Co-authorship network of co-authors of Géraldine Cancel‐Tassin

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Cancel‐Tassin. A scholar is included among the top collaborators of Géraldine Cancel‐Tassin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Cancel‐Tassin. Géraldine Cancel‐Tassin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cussenot, Olivier, Antoine Pilon, Jérôme Guechot, et al.. (2023). Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic risk. British Journal of Urology. 131(6). 745–754. 5 indexed citations
2.
Cancel‐Tassin, Géraldine, et al.. (2023). Molecular Anatomy of Prostate Cancer and Its Implications in Active Surveillance and Early Intervention Strategies. SHILAP Revista de lepidopterología. 2(4). 300–319.
3.
Cussenot, Olivier, et al.. (2022). Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?. British Journal of Urology. 130(5). 582–585. 1 indexed citations
4.
Houy, Alexandre, Olivier Ganier, Florent Dingli, et al.. (2022). Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor. The American Journal of Human Genetics. 109(12). 2196–2209. 3 indexed citations
5.
Lotan, Tamara L., Harsimar Kaur, Daniela C. Salles, et al.. (2021). Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. Modern Pathology. 34(6). 1185–1193. 67 indexed citations
6.
Compérat, Éva, et al.. (2020). The Genetic Complexity of Prostate Cancer. Genes. 11(12). 1396–1396. 12 indexed citations
7.
Compérat, Éva, et al.. (2020). Diagnosis of prostate cancer in one day: The benefits of cytology in tumour detection. Cytopathology. 32(2). 211–216. 1 indexed citations
8.
Zhang-Yin, Jules, C. Provost, Géraldine Cancel‐Tassin, et al.. (2020). A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models. Nuclear Medicine and Biology. 84-85. 88–95. 15 indexed citations
9.
Wendeu‐Foyet, Gaëlle, Sylvie Cénée, Yves Akoli Koudou, et al.. (2020). Circadian genes polymorphisms, night work and prostate cancer risk: Findings from the EPICAP study. International Journal of Cancer. 147(11). 3119–3129. 19 indexed citations
10.
Cancel‐Tassin, Géraldine, Éva Compérat, Pierre Mozer, et al.. (2016). Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy. World Journal of Urology. 34(10). 1389–1395. 14 indexed citations
11.
Cussenot, Olivier & Géraldine Cancel‐Tassin. (2015). Le point sur la prédisposition génétique pour le cancer de la prostate. Bulletin du Cancer. 102(1). 53–56. 5 indexed citations
12.
Renard-Penna, R., Géraldine Cancel‐Tassin, Éva Compérat, et al.. (2015). Imagerie de diffusion comme marqueur non invasif de l’agressivité du cancer de prostate : comparaison aux marqueurs biologiques, histologiques, immuno-histochimiques et moléculaires. Progrès en Urologie. 25(13). 829–829. 1 indexed citations
13.
Cornu, Jean‐Nicolas, et al.. (2010). Olfactory Detection of Prostate Cancer by Dogs Sniffing Urine: A Step Forward in Early Diagnosis. European Urology. 59(2). 197–201. 209 indexed citations
14.
Cancel‐Tassin, Géraldine, Alain Latil, Antoine Valéri, et al.. (2001). PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. European Journal of Human Genetics. 9(2). 135–142. 43 indexed citations
15.
Duyckaerts, Charles, Alexandra Dürr, Géraldine Cancel‐Tassin, & Alexis Brice. (1999). Nuclear inclusions in spinocerebellar ataxia type 1. Acta Neuropathologica. 97(2). 201–207. 48 indexed citations
16.
Takano, Hiroki, Géraldine Cancel‐Tassin, Takeshi Ikeuchi, et al.. (1998). Close Associations between Prevalences of Dominantly Inherited Spinocerebellar Ataxias with CAG-Repeat Expansions and Frequencies of Large Normal CAG Alleles in Japanese and Caucasian Populations. The American Journal of Human Genetics. 63(4). 1060–1066. 160 indexed citations
17.
Cancel‐Tassin, Géraldine, Isabelle Gourfinkel‐An, Giovanni Stévanin, et al.. (1998). Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease. Human Mutation. 11(1). 23–27. 45 indexed citations
18.
Trottier, Yvon, Géraldine Cancel‐Tassin, Isabelle An-Gourfinkel, et al.. (1998). Heterogeneous Intracellular Localization and Expression of Ataxin-3. Neurobiology of Disease. 5(5). 335–347. 86 indexed citations
19.
Benomar, Ali, Giovanni Stévanin, Géraldine Cancel‐Tassin, et al.. (1995). The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12–p21.1. Nature Genetics. 10(1). 84–88. 126 indexed citations
20.
Chneiweiss, Hervé, Giovanni Stévanin, Géraldine Cancel‐Tassin, et al.. (1993). Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity. Brain. 116(6). 1497–1508. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven L. Carroll Breakdown of academic impact, for papers by Mary B. Davis Breakdown of academic impact, for papers by Iver A. Langmoen Breakdown of academic impact, for papers by Murat Günel Breakdown of academic impact, for papers by Wim G.M. Spliet Breakdown of academic impact, for papers by Claude‐Alain Maurage Breakdown of academic impact, for papers by Federico Zara Breakdown of academic impact, for papers by Kinga Szigeti Breakdown of academic impact, for papers by Ana Martín-Villalba Breakdown of academic impact, for papers by Wolfgang Roggendorf
Rankless by CCL
2026